Prognostic factors in thyroid carcinoma.
Thyroid carcinomas range from the most indolent to the most aggressive human malignancies. A variety of clinical and pathologic factors can be used to help predict behavior and determine appropriate therapy. New molecular biologic techniques show promise in further refining the assessment of prognosis in thyroid cancer patients.
Treseler
P A
PA
Department of Pathology, University of California, San Francisco, Mount Zion Medical Center, San Francisco, California 94115, USA.
Clark
O H
OH
D014408:Biomarkers, Tumor / Q000032:analysis; D004273:DNA, Neoplasm / Q000235:genetics; D006801:Humans; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009857:Oncogenes; D011003:Ploidies; D011379:Prognosis; D012307:Risk Factors; D013964:Thyroid Neoplasms / Q000473:pathology* / Q000628:therapy
D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm